Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
50.48%
0%
50.48%
6 Months
28.86%
0%
28.86%
1 Year
69.55%
0%
69.55%
2 Years
112.2%
0%
112.2%
3 Years
80.04%
0%
80.04%
4 Years
-25.17%
0%
-25.17%
5 Years
29.32%
0%
29.32%
IBL Healthcare Ltd. for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
8.11%
EBIT Growth (5y)
3.14%
EBIT to Interest (avg)
10.43
Debt to EBITDA (avg)
1.92
Net Debt to Equity (avg)
0.15
Sales to Capital Employed (avg)
1.55
Tax Ratio
79.85%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
18.71%
ROE (avg)
12.45%
Valuation key factors
Factor
Value
P/E Ratio
24
Industry P/E
Price to Book Value
2.17
EV to EBIT
12.31
EV to EBITDA
12.06
EV to Capital Employed
2.21
EV to Sales
1.15
PEG Ratio
0.02
Dividend Yield
NA
ROCE (Latest)
17.92%
ROE (Latest)
8.97%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Bearish
Mildly Bearish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Bearish
Moving Averages
Bearish (Daily)
KST
Bearish
Bullish
Dow Theory
Mildly Bullish
Mildly Bearish
OBV
Mildly Bullish
Bullish
Shareholding Snapshot
No data for shareholding present.
Shareholding Compare (%holding) 
No data for shareholding present.
Quarterly Results Snapshot (Consolidated) - Dec'25 - QoQ
Dec'25
Sep'25
Change(%)
Net Sales
971.10
1,120.90
-13.36%
Operating Profit (PBDIT) excl Other Income
94.20
123.80
-23.91%
Interest
12.00
9.20
30.43%
Exceptional Items
0.00
0.00
Consolidate Net Profit
35.90
69.70
-48.49%
Operating Profit Margin (Excl OI)
93.60%
108.50%
-1.49%
USD in Million.
Net Sales
QoQ Growth in quarter ended Dec 2025 is -13.36% vs -4.83% in Sep 2025
Consolidated Net Profit
QoQ Growth in quarter ended Dec 2025 is -48.49% vs -4.39% in Sep 2025
Annual Results Snapshot (Consolidated) - Jun'25
Jun'25
Jun'24
Change(%)
Net Sales
4,322.50
3,603.40
19.96%
Operating Profit (PBDIT) excl Other Income
423.50
82.00
416.46%
Interest
60.20
67.40
-10.68%
Exceptional Items
0.00
-10.10
100.00%
Consolidate Net Profit
208.40
7.60
2,642.11%
Operating Profit Margin (Excl OI)
96.10%
20.70%
7.54%
USD in Million.
Net Sales
YoY Growth in year ended Jun 2025 is 19.96% vs -10.54% in Jun 2024
Consolidated Net Profit
YoY Growth in year ended Jun 2025 is 2,642.11% vs -97.54% in Jun 2024
About IBL Healthcare Ltd. 
IBL Healthcare Ltd.
Retailing
IBL HealthCare Limited is a Pakistan-based company engaged in marketing, selling and distribution of healthcare products. The Company is engaged in providing a range of healthcare and nutritional products. The Company's divisions include Mead Johnson Nutrition, Nestle Health Science, Brand Plus, Medical Disposable Division and Principle Health Care. The Mead Johnson Nutrition division offers approximately 70 products, such as Enfamama A+, Enfamil A+ Stage 1, Enfamil A+ Stage 2, Enfagrow A+ Stage 3 and Sustagen school 6+. Nestle Health Science offers nutritional solutions for people with specific dietary needs related to illnesses, disease states or the challenges of different life stages. It offers products, such as Resource Diabetes and Resource Optimum. The Brand Plus division provides a range of baby cereals. The Medical Disposable division consist a range of medical disposables. The Principle Health Care division is a vitamin, mineral and food supplement producer.
Company Coordinates 
Company Details
9th Floor, N.I.C. Building, Abbasi Shaheed Road KARACHI None : 75530
Registrar Details






